Curated News
By: NewsRamp Editorial Staff
September 14, 2026
Med-X Advances Nature-Cide as Nasdaq Listing Nears
TLDR
- Med-X advances Nature-Cide as its main growth platform before a planned Nasdaq listing, targeting expanded commercial adoption and acquisitions.
- Nature-Cide develops natural pesticide products, recently obtained OMRI certification, and Med-X emphasizes formulation science, testing, and professional pest-control adoption.
- Med-X's Nature-Cide offers a safer, all-natural pest control alternative, potentially benefiting organic farming, livestock, and healthier environments.
- Med-X, preparing for a Nasdaq debut, owns Nature-Cide, Thermal-Aid, and Malibu Brands, with Nature-Cide spanning indoor, outdoor, dust, and granular products.
Impact - Why it Matters
Med-X's push to expand Nature-Cide comes as consumer and regulatory demand for safer, natural pest-control alternatives accelerates. The company's recent OMRI certification could open doors to organic agriculture and livestock markets, which often require certified inputs. For investors, Med-X's planned Nasdaq listing under the ticker MXRX offers a potential opportunity to participate in the growing biological pest control sector. If successful, Med-X could challenge conventional chemical pesticide providers and provide professionals and consumers with more environmentally friendly options. The outcome of its commercialization and acquisition strategy will be closely watched as a bellwether for natural pest management adoption.
Summary
Med-X (Reserved NASDAQ: MXRX), a privately held health and wellness company preparing for a planned Nasdaq listing, is advancing its Nature-Cide brand as the primary growth platform within its portfolio. Nature-Cide develops and commercializes natural pesticide and pest-management products for professional operators and consumers, with applications spanning residential pest control, agriculture, commercial facilities, municipalities, and other markets. Med-X also owns Thermal-Aid, a line of reusable heating and cooling pain-relief products, and Malibu Brands, which focuses on essential oil-based wellness solutions.
Nature-Cide has expanded from its origins in localized pest-management applications into a portfolio of indoor, outdoor, dust, and granular products, with Med-X emphasizing formulation science, testing, and adoption by professional pest-control operators. The company recently obtained OMRI certification for key products, potentially broadening opportunities in organic food production, livestock operations, and other agricultural applications. Management is targeting expanded commercial adoption, production capacity, acquisitions, and research and development as Med-X moves toward its anticipated public-market debut. To view the Med-X investor presentation, visit https://ibn.fm/Ai648.
The announcement was distributed by InvestorWire, a specialized communications platform that is part of the Dynamic Brand Portfolio @ IBN, which provides wire-grade press release syndication, article and editorial syndication to 5,000+ outlets, enhanced press release enhancement, social media distribution, and tailored corporate communications solutions. For more information, visit www.medx-rx.com or https://www.InvestorWire.com.
Source Statement
This curated news summary relied on content distributed by InvestorBrandNetwork (IBN). Read the original source here, Med-X Advances Nature-Cide as Nasdaq Listing Nears
